Fresh analysis indicates that individuals who discontinue new weight-loss injections like semaglutide or tirzepatide can put back on shed pounds much more quickly than those who halt traditional lifestyle plans.
Research printed in a major medical journal shows that while overweight people frequently drop a large proportion of their total mass while using the jabs, the weight comes back at an estimated rate of 0.8 kg per month upon discontinuation.
"Users using these medications need to be aware of the potential of fast weight regain when the medication concludes," cautioned lead investigator Dr. Susan Jebb.
This pace of regain suggests a reversion to starting mass in about one and a half years.
Weighing Approaches
The analysis, which examined dozens of studies involving thousands of participants, compared the outcomes of these new drugs with older methods.
Scientists emphasize that individuals who shed pounds through dieting usually see a slower weight regain—perhaps 0.1 kg a month—after stopping.
Understanding the Quick Rebound
Doctors believe the way of the jabs explains the heightened rebound.
These medications copy a natural hormone called glucagon-like peptide-1, which moderates appetite.
"Long-term administration of the hormone levels several times higher than the body's typical production could lead to the body to generate a reduced amount of its own natural hormone, and may also reduce responsiveness to its effects," said Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this GLP-1 'fix' results in hunger is unsuppressed, making binge eating much more probable."
An Ongoing Disease?
Medical guidelines recommend the jabs for people with obesity-related health risks, accompanied by recommended diet and exercise modifications.
Many experts say that, considering the likelihood of weight regain, the treatment is often ongoing.
This perspective is supported by drug manufacturers, who note that the results "emphasize the chronic nature of excess weight," similar to managing diseases like high blood pressure.
Patient Testimonies
People who have discontinued the medication describe a sudden resurgence of appetite.
"I experienced something that goes on and you're instantly extremely hungry," said a patient.
This challenge is worsened if patients have not established sustainable dietary or behavioural changes during therapy.
Growing Interest
Figures suggest that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with interest being substantial.
- Use is more common among females compared to males.
- The middle-aged age group shows the greatest level of interest.
- Many access the medications through private healthcare rather than public health services.
In conclusion, experts stress that while the jabs are effective agents for weight loss, they are not a permanent cure and lasting health benefits likely depends on ongoing behavioural changes.
